Neuroone Medical Technologies (NMTC) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Neuroone Medical Technologies (NMTC) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 5.69% |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn | -35.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.68% |
| Mar 31, 2026 | -31.14% |
| Dec 31, 2025 | -35.84% |
| Sep 30, 2025 | -37.81% |
| Jun 30, 2025 | -33.42% |
| Mar 31, 2025 | -32.49% |
| Dec 31, 2024 | -24.44% |
| Sep 30, 2024 | -20.72% |
| Jun 30, 2024 | -19.49% |
| Mar 31, 2024 | -5.13% |
| Dec 31, 2023 | 50.89% |
| Sep 30, 2023 | 48.69% |
| Jun 30, 2023 | 86.16% |
| Mar 31, 2023 | 82.19% |
| Dec 31, 2022 | 54.58% |
| Sep 30, 2022 | 58.33% |
| Jun 30, 2022 | 101.63% |
| Mar 31, 2022 | 78.14% |
| Dec 31, 2021 | 41.68% |
| Sep 30, 2021 | 34.51% |